Insider Shareholders with Direct Ownership of Viracta Therapeutics, Inc. (VIRX)
This section provides a comprehensive overview of the insiders with direct ownership of Viracta Therapeutics, Inc. (VIRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Viracta Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 368,065 | 68,923 | 839,741 $167,948 | 20 |
Nov 25, 2024
Added 2.92%
|
|
| 126,478 | 0 | 126,478 $25,295 | 13 |
Nov 25, 2024
Added 6.67%
|
|
|
Daniel R. Chevallard
CFO and COO |
97,777 | 40,231 | 102,306 $20,461 | 23 |
Feb 27, 2024
Reduced 3.22%
|
|
Mark Rothera
President and CEO |
100,000 | 0 | 100,000 $20,000 | 2 |
Dec 01, 2023
Added 32.39%
|
|
Lisa Rojkjaer
Chief Medical Officer |
63,639 | 15,552 | 48,087 $9,617 | 14 |
Feb 27, 2023
Reduced 4.29%
|